Entropy Technologies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
18,484
-185,093
-91% -$14.9M 0.06% 410
2026
Q1
$17.6M Buy
+203,577
New +$19.5M 0.81% 10
2025
Q4
Sell
-13,170
Closed -$1.25M 1047
2025
Q3
$1.25M Buy
+13,170
New +$1.21M 0.09% 279
2025
Q2
Sell
-5,118
Closed -$460K 935
2025
Q1
$460K Sell
5,118
-58,382
-92% -$5.22M 0.04% 450
2024
Q4
$5.07M Buy
+63,500
New +$5.5M 0.52% 34
2024
Q3
Sell
-40,217
Closed -$3.17M 860
2024
Q2
$3.17M Buy
+40,217
New +$3.3M 0.34% 83

Other funds holding MDT

Entropy Technologies's MDT Position: Q2 2026 in Review

Entropy Technologies reduced its Medtronic (MDT) stake by 91% in Q2 2026, selling an estimated $14.9M and leaving 18,484 shares worth $1.45M. The position accounts for 0.06% of the portfolio, ranked #410.

Entropy Technologies first reported a position in MDT in Q2 2024 and has held it in 6 quarters since. The position peaked at $17.6M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Entropy Technologies held 18,484 shares of Medtronic worth $1.45M as of Q2 2026.
  • Entropy Technologies sold 185,093 Medtronic shares in Q2 2026, an estimated $14.9M.
  • Medtronic made up 0.06% of Entropy Technologies's portfolio in Q2 2026, its #410 holding.
  • Entropy Technologies first reported a position in Medtronic in Q2 2024 and has held it in 6 quarters since.
  • Entropy Technologies's Medtronic position peaked at $17.6M in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.